Correlation between apparent diffusion coefficient and pathological characteristics of patients with invasive breast cancer

Background There is insufficient research on the correlation between the apparent diffusion coefficient and clinicopathological characteristics of breast cancer patients. The present study is to investigate the correlation between the apparent diffusion coefficient and pathological characteristics of patients with invasive breast cancer. Methods From January 2019 to September 2020, 122 cases of invasive breast cancer and 21 cases of benign tumors were retrospectively enrolled. The apparent diffusion coefficient was compared between the two groups, and the correlation between the apparent diffusion coefficient and the pathological characteristics of the patients with invasive breast cancer were analyzed. Results Compared with the benign tumor group, the apparent diffusion coefficient in the invasive breast cancer group was significantly lower (0.89±0.17 vs. 1.47±0.27 10−3 mm2/s, P=0.000). Using the apparent diffusion coefficient to diagnose patients with invasive breast cancer, the area under receiver operating characteristic (ROC) curve was 0.966±0.021 [95% confidence interval (CI): 0.924–1.000, P=0.000], and the best diagnostic cut-off value was 1.16 (10−3 mm2/s), with sensitivity and specificity of 0.905 and 0.902, respectively. The apparent diffusion coefficient was used to diagnose vascular tumor thrombus in patients with invasive breast cancer. The area under the ROC curve was 0.641±0.068 (95% CI: 0.508–0.774, P=0.047), and the best diagnostic threshold was 0.835 (10−3 mm2/s), with sensitivity and specificity of 0.676 and 0.650, respectively. The apparent diffusion coefficient in patients with high expression of Ki-67 (%) was significantly reduced (0.87±0.17 vs. 1.00±0.16 10−3 mm2/s, P=0.000). The apparent diffusion coefficient was not significantly correlated with age, menopause, lesion size, estrogen receptor, progesterone receptor, or lymph node metastasis in patients with invasive breast cancer (P>0.05). Conclusions In patients with invasive breast cancer the apparent diffusion coefficient was significantly reduced. It was able to differentiate invasive breast cancer and vascular tumor thrombus, and was also related to Ki-67 (%) high expression.

[1]  Canjian Chen,et al.  The expression of KI-67 and LEF-1 in patients after breast cancer resection and its effects on patients' prognosis. , 2020, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

[2]  M. Herranz,et al.  Apparent diffusion coefficient: Potential biomarker for complete response after neo‐adjuvant chemotherapy in breast cancer , 2020, The breast journal.

[3]  W. Han,et al.  Ki-67 Expression is a Significant Prognostic Factor Only When Progesterone Receptor Expression is Low in Estrogen Receptor-Positive and HER2-Negative Early Breast Cancer , 2019, Journal of oncology.

[4]  Xiao-Ting Li,et al.  Texture Analysis of Dynamic Contrast-Enhanced MRI in Evaluating Pathologic Complete Response (pCR) of Mass-Like Breast Cancer after Neoadjuvant Therapy , 2019, Journal of oncology.

[5]  F. Prato,et al.  DCE-MRI assessment of response to neoadjuvant SABR in early stage breast cancer: Comparisons of single versus three fraction schemes and two different imaging time delays post-SABR , 2019, Clinical and translational radiation oncology.

[6]  M. de Camargo Cancela,et al.  Association of cervical and breast cancer mortality with socioeconomic indicators and availability of health services. , 2019, Cancer epidemiology.

[7]  C. Castañeda,et al.  Latin American Study of Hereditary Breast and Ovarian Cancer LACAM: A Genomic Epidemiology Approach , 2019, Front. Oncol..

[8]  N. Gudzenko,et al.  EPIDEMIOLOGY OF BREAST CANCER IN UKRAINE WITH CONSIDERATION OF THE FACTORS OF THE CHORNOBYL ACCIDENT. , 2019, Problemy radiatsiinoi medytsyny ta radiobiolohii.

[9]  M. F. Ariffin,et al.  Modelling excess mortality among breast cancer patients in the North East Region of Peninsular Malaysia, 2007–2011: a population-based study , 2019, BMC Public Health.

[10]  Lihua Li,et al.  Joint Prediction of Breast Cancer Histological Grade and Ki-67 Expression Level Based on DCE-MRI and DWI Radiomics , 2019, IEEE Journal of Biomedical and Health Informatics.

[11]  C. Hsiung,et al.  Mortality of Pregnancy Following Breast Cancer Diagnoses in Taiwanese Women. , 2019, The oncologist.

[12]  G. Spinelli,et al.  Expression of ER, PgR, HER-2, and Ki-67 in core biopsies and in definitive histological specimens in patients with locally advanced breast cancer treated with neoadjuvant chemotherapy , 2019, Cancer Chemotherapy and Pharmacology.

[13]  W. Weichert,et al.  Risk stratification in luminal-type breast cancer: Comparison of Ki-67 with EndoPredict test results , 2019, Breast.

[14]  C. Gatsonis,et al.  MRI Evaluation of the Contralateral Breast in Women with Recently Diagnosed Breast Cancer: 2-Year Follow-up. , 2019, Journal of breast imaging.

[15]  S. Partridge,et al.  Apparent diffusion coefficient cannot predict molecular subtype and lymph node metastases in invasive breast cancer: a multicenter analysis , 2019, BMC Cancer.

[16]  B. Choi Associations Between Apparent Diffusion Coefficient Values and the Prognostic Factors of Breast Cancer. , 2019, Journal of computer assisted tomography.

[17]  Yinan Ji,et al.  Changes in Apparent Diffusion Coefficient as Surrogate Marker for Changes in Ki-67 Index Due to Neoadjuvant Chemotherapy in Patients with Invasive Breast Cancer. , 2019, Academic radiology.

[18]  Weihua Guo,et al.  Diagnostic performance of minimum apparent diffusion coefficient value in differentiating the invasive breast cancer and ductal carcinoma in situ , 2019, Journal of cancer research and therapeutics.

[19]  Şehnaz Tezcan,et al.  Diffusion-Weighted Imaging of Breast Cancer: Correlation of the Apparent Diffusion Coefficient Value with Pathologic Prognostic Factors. , 2019, European journal of breast health.

[20]  Kui Li,et al.  Diagnostic value of diffusion-weighted imaging-derived apparent diffusion coefficient and its association with histological prognostic factors in breast cancer , 2019, Oncology letters.

[21]  M. Mańczuk,et al.  Breast cancer mortality trends in Europe among women in perimenopausal and postmenopausal age (45+) , 2019, Archives of medical science : AMS.

[22]  P. Omoregie,et al.  Epidemiology and Challenges of Managing Breast Cancer in Keffi, North-Central Nigeria: A Preliminary Report , 2019, Nigerian medical journal : journal of the Nigeria Medical Association.

[23]  A. Kasaeian,et al.  Association between Ki-67 expression and clinicopathological features in prognosis of breast cancer: A retrospective cohort study , 2019, Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences.

[24]  N. Sood Ki-67, an elusive marker in the prognosis of breast cancer , 2019, The Indian journal of medical research.

[25]  M. Nakano,et al.  Ki-67 index value and progesterone receptor status can predict prognosis and suitable treatment in node-negative breast cancer patients with estrogen receptor-positive and HER2-negative tumors. , 2018, Oncology letters.